Newell K A, Bruce D S, Cronin D C, Woodle E S, Millis J M, Piper J B, Huss E, Thistlethwaite J R
Department of Surgery, University of Chicago, Illinois 60637, USA.
Transplantation. 1996 Nov 15;62(9):1353-6. doi: 10.1097/00007890-199611150-00030.
Although bladder drainage of pancreatic exocrine secretions has been reported to decrease morbidity and improve pancreas allograft survival, significant complications remain associated with this technique. Furthermore, this technique requires systemic venous drainage of pancreas allografts. Evidence suggests that portal venous drainage of pancreas grafts prevents hyperinsulinemia and improves lipoprotein composition. This report documents our initial experience with portal venous and enteric exocrine drainage of pancreas allografts (portal/enteric technique) and compares it with the standard technique of systemic venous and bladder exocrine drainage (systemic/bladder technique). Patient and allograft survival, as well as allograft function, were comparable for the two procedures. There were no significant technical complications in this pilot series. Enteric exocrine drainage was associated with a significant reduction in the incidence of acidosis and dehydration when compared with bladder drainage (P<0.005). The portal/enteric technique also avoided reoperation for enteric conversion, as was required by 33% of patients in the systemic/bladder group. The incidence and outcome of allograft rejection were similar for the two techniques. These data suggest that combined pancreas/kidney transplantation with portal venous and enteric exocrine drainage is safe and results in outcomes similar to the standard technique, while eliminating many complications of bladder drainage. These findings should encourage additional studies to determine the consequences of portal venous drainage.
尽管据报道胰外分泌液的膀胱引流可降低发病率并提高胰腺移植存活率,但该技术仍存在显著并发症。此外,该技术需要对胰腺移植进行体静脉引流。有证据表明,胰腺移植的门静脉引流可预防高胰岛素血症并改善脂蛋白组成。本报告记录了我们在胰腺移植门静脉和肠道外分泌引流(门静脉/肠道技术)方面的初步经验,并将其与体静脉和膀胱外分泌引流的标准技术(体静脉/膀胱技术)进行了比较。两种手术的患者和移植存活率以及移植功能相当。在这个试点系列中没有明显的技术并发症。与膀胱引流相比,肠道外分泌引流与酸中毒和脱水发生率的显著降低相关(P<0.005)。门静脉/肠道技术还避免了因肠道改道而进行的再次手术,而体静脉/膀胱组33%的患者需要进行这种手术。两种技术的移植排斥发生率和结果相似。这些数据表明,联合胰腺/肾脏移植采用门静脉和肠道外分泌引流是安全的,其结果与标准技术相似,同时消除了膀胱引流的许多并发症。这些发现应鼓励进行更多研究以确定门静脉引流的后果。